主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NUVB
#3996
Nuvation Bio Inc.
5.9
2
+5.71%
版块:
基础:
利润货币:
日范围
年范围
日变化
+5.71%
每月变动
+5.53%
6个月变化
+98.66%
年变化
+203.59%
前一天收盘价
5.6
0
Open
5.7
9
Bid
Ask
Low
5.7
9
High
5.9
2
交易量
1 640
市场
股票
医疗保健
NUVB
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
新闻
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update
Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma
Nuvation Bio股票因Ibtrozi销售势头强劲维持B.Riley买入评级
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)
Truist Securities上调Nuvation Bio股票目标价至13美元,看好Ibtrozi市场表现
Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake
Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study
Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround
H.C. Wainwright下调Nuvation Bio目标价至17美元
Nuvation Bio stock price target lowered to $17 at H.C. Wainwright